| Period Ending: |
LTM
(Last Twelve Months) |
2025
(Q3)
09-30 |
2025
(Q2)
06-30 |
2025
(Q1)
03-31 |
2024
(Q4)
12-31 |
2024
(Q3)
09-30 |
|---|---|---|---|---|---|---|
| Report Filing | 2025-09-30 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Revenue | 2.92 | 1.54 | 0.173 | 0.171 | 1.04 | 0.984 |
| Cost of Revenue | 4.11 | 0.055 | 0.001 | 0.001 | 4.05 | 3.45 |
| Gross Profit | -1.18 | 1.49 | 0.173 | 0.17 | -3.01 | -2.47 |
| Operating Expenses | 31.18 | 24.81 | 2.86 | 1.83 | 1.68 | 4.54 |
| Research & Development | 0.182 | 0 | 0.083 | 0.099 | 0 | 0 |
| Selling, General and Administrative | 31.12 | 24.81 | 2.86 | 1.83 | 1.63 | 4.49 |
| Other Operating Expenses | -0.131 | 0 | -0.083 | -0.099 | 0.051 | 0.047 |
| Operating Income | -32.36 | -23.32 | -2.69 | -1.66 | -4.69 | -7.01 |
| Net Non-Operating Interest | 0.061 | 0 | 0.028 | 0.033 | 0 | 0 |
| Interest Income | 0.063 | 0 | 0.029 | 0.034 | 0 | 0 |
| Interest Expense | 0.002 | 0 | 0.001 | 0.001 | 0 | 0 |
| Equity & Other Income/(Expense) | -182.8 | -183.3 | 0 | 0 | 0.574 | 0.208 |
| Income Before Tax | -215.1 | -206.7 | -2.66 | -1.62 | -4.12 | -6.8 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -215.1 | -206.7 | -2.66 | -1.62 | -4.12 | -6.8 |
| Depreciation and Amortization | 0.117 | 0.055 | 0.001 | 0.001 | 0.06 | 0.067 |
| EBITDA | -32.24 | -23.26 | -2.69 | -1.66 | -4.63 | -6.94 |
| Earnings Per Share (EPS) | -0.61 | -0.31 | -0.17 | -0.13 | 0 | 0 |
| Diluted Earnings Per Share | -0.61 | -0.31 | -0.17 | -0.13 | 0 | 0 |
| Weighted Average Shares Outstanding | 666.9 | 666.9 | 15.59 | 13.16 | 0 | 0 |
| Diluted Weighted Average Shares Outstanding | 666.9 | 666.9 | 15.59 | 13.16 | 0 | 0 |
